It is known that the vimentin promoter is a direct target of β-catenin/TCF transactivation in breast cancer cells and the cytoplasmic and nuclear localization of β-catenin in mammary human epithelial cell lines is associated with vimentin expression leading to high invasive/migratory potential [19]. This evidence concerns the gene VIM and breast cancer.